E Albengres
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Transplantation top 10%
Papers in
- Pharmacology 19
- Drug-Induced Adverse Reactions 8
- Antibiotics Pharmacokinetics and Efficacy 7
- Co-authors
- Saı̈k UrienJean‐Paul TillementJ P TillementJ.P. TillementJean-Claude DuchéP RiantFrançoise HervéTillement Jp
- Journals
- Biochemical Pharmacology (3 papers)Molecular Pharmacology (2 papers)Drug Safety (2 papers)Pharmacology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- FranceSwitzerlandSweden
In The Last Decade
E Albengres
65 papers receiving 932 citations
Peers
Comparison fields: 5 of 114
- Pharmacology 252
- Pharmacology 113
- Transplantation 21
- Oncology 203
- Toxicology 23
Countries citing papers authored by E Albengres
This map shows the geographic impact of E Albengres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Albengres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Albengres more than expected).
Fields of papers citing papers by E Albengres
This network shows the impact of papers produced by E Albengres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Albengres. The network helps show where E Albengres may publish in the future.
Co-authors
The 25 scholars most cited alongside E Albengres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 2 | |
| 2 | Bérylliose pulmonaire chez un prothésiste dentaire | 2000 | 1 |
| 3 | 2000 | 9 | |
| 4 | 1998 | 9 | |
| 5 | 1997 | 6 | |
| 6 | 1997 | 19 | |
| 7 | 1996 | 40 | |
| 8 | 1996 | 3 | |
| 9 | 1993 | 22 | |
| 10 | 1993 | 8 | |
| 11 | 1992 | 28 | |
| 12 | 1990 | 4 | |
| 13 | 1989 | 12 | |
| 14 | 1988 | 20 | |
| 15 | 1988 | 15 | |
| 16 | Features of the French postmarketing drug surveillance system. Application to cutaneous effects of nonsteroidal antiinflammatory drugs. | 1988 | 3 |
| 17 | [How to diagnose a cutaneous complication of a drug. Application to vascular purpura]. | 1987 | 10 |
| 18 | [Lyell's syndrome and ectodermosis pluriorificialis during treatment with oxicams: 11 cases]. | 1985 | 6 |
| 19 | 1984 | 18 | |
| 20 | [Pharmacological approach to the rational use of cardiotonic heterosides]. | 1977 | 5 |
About E Albengres
E Albengres is a scholar working on Transplantation, Pharmacology, Clinical Biochemistry, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 68 papers that have together received 986 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (9 papers), Drug-Induced Adverse Reactions (8 papers), Pharmaceutical studies and practices (8 papers), Protein Interaction Studies and Fluorescence Analysis (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Metabolism and Genetic Disorders (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Urticaria and Related Conditions (6 papers). The work is most often cited by research in Pharmacology (252 citations), Pharmacology (113 citations), Transplantation (21 citations), Oncology (203 citations) and Toxicology (23 citations). E Albengres has collaborated with scholars based in France, Switzerland and Sweden. Frequent co-authors include Saı̈k Urien, Jean‐Paul Tillement, J P Tillement, J.P. Tillement, Jean-Claude Duché, P Riant, Françoise Hervé, Tillement Jp, Françoise Brée and Roland Zini. Their work appears in journals such as Biochemical Pharmacology, Molecular Pharmacology, Drug Safety, Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.